Clinical Trial: N-acetylcysteine in the Treatment of Bulimia Nervosa

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title:

Brief Summary: The specific aim of this study is to evaluate the efficacy, tolerability, and safety of N-acetylcysteine (NAC) in the treatment on bulimia nervosa.

Detailed Summary:
Sponsor: Lindner Center of HOPE

Current Primary Outcome: The primary outcome measure will be the weekly frequency of binge-purge episodes. [ Time Frame: 12 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Lindner Center of HOPE

Dates:
Date Received: December 14, 2009
Date Started: December 2009
Date Completion:
Last Updated: March 4, 2014
Last Verified: March 2014